Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Precision BioSciences, Inc. (DTIL) had Return on Equity of -69.07% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.02M |
|
$-23.52M |
|
-- |
|
$0.02M |
|
$21.89M |
|
$-21.88M |
|
$-1.64M |
|
$-23.52M |
|
$-22.83M |
|
$-23.52M |
|
$-23.52M |
|
$-23.52M |
|
$-22.83M |
|
$-21.88M |
|
$-21.36M |
|
11.05M |
|
11.05M |
|
$-2.13 |
|
$-2.13 |
|
| Balance Sheet Financials | |
$70.26M |
|
$2.36M |
|
$38.67M |
|
$108.93M |
|
$13.57M |
|
$22.35M |
|
$61.31M |
|
$74.87M |
|
$34.05M |
|
$33.45M |
|
$34.05M |
|
11.64M |
|
| Cash Flow Statement Financials | |
$-39.32M |
|
$-0.33M |
|
$15.99M |
|
$108.47M |
|
$84.81M |
|
$-23.66M |
|
$5.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.18 |
|
-- |
|
-- |
|
0.40 |
|
0.66 |
|
100.00% |
|
-121538.90% |
|
-121538.90% |
|
-- |
|
-130666.70% |
|
-130666.70% |
|
$-39.38M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-69.07% |
-70.32% |
|
-21.59% |
|
-41.70% |
|
$2.93 |
|
$-3.57 |
|
$-3.56 |
|